ArticleCancer medicine2019

CRM197 reverses paclitaxel resistance by inhibiting the NAC-1/Gadd45 pathway in paclitaxel-resistant ovarian cancer cells.

Xiao-Han Tang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.